These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 11862382

  • 61. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
    Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W.
    EMBO J; 1997 Mar 03; 16(5):1045-55. PubMed ID: 9118943
    [Abstract] [Full Text] [Related]

  • 62. Regulation of MHC class II genes: lessons from a disease.
    Mach B, Steimle V, Martinez-Soria E, Reith W.
    Annu Rev Immunol; 1996 Mar 03; 14():301-31. PubMed ID: 8717517
    [Abstract] [Full Text] [Related]

  • 63. Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.
    Prod'homme T, Dekel B, Barbieri G, Lisowska-Grospierre B, Katz R, Charron D, Alcaide-Loridan C, Pollack S.
    Immunogenetics; 2003 Nov 03; 55(8):530-9. PubMed ID: 14574520
    [Abstract] [Full Text] [Related]

  • 64. The bare lymphocyte syndrome and the regulation of MHC expression.
    Reith W, Mach B.
    Annu Rev Immunol; 2001 Nov 03; 19():331-73. PubMed ID: 11244040
    [Abstract] [Full Text] [Related]

  • 65. [Construction of eukaryotic expression vectors containing different haplotype cDNA of human CIITA gene].
    Bai XJ, Zhang XQ, Hong XJ.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun 03; 15(6):445-9. PubMed ID: 17594811
    [Abstract] [Full Text] [Related]

  • 66. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.
    Brown JA, Rogers EM, Boss JM.
    Nucleic Acids Res; 1998 Sep 15; 26(18):4128-36. PubMed ID: 9722631
    [Abstract] [Full Text] [Related]

  • 67. Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA.
    Quan V, Towey M, Sacks S, Kelly AP.
    Immunogenetics; 1999 Oct 15; 49(11-12):957-63. PubMed ID: 10501838
    [Abstract] [Full Text] [Related]

  • 68. MHC class II deficiency: definition of a new complementation group.
    Villard J, Mach B, Reith W.
    Immunobiology; 1997 Dec 15; 198(1-3):264-72. PubMed ID: 9442397
    [Abstract] [Full Text] [Related]

  • 69. Nonsense mutations in human transcobalamin II deficiency.
    Li N, Rosenblatt DS, Seetharam B.
    Biochem Biophys Res Commun; 1994 Nov 15; 204(3):1111-8. PubMed ID: 7980584
    [Abstract] [Full Text] [Related]

  • 70. Repression of allo-cell transplant rejection through CIITA ribonuclease P+ hepatocyte.
    Guo R, Zou P, Fan HH, Gao F, Shang QX, Cao YL, Lu HZ.
    World J Gastroenterol; 2003 May 15; 9(5):1077-81. PubMed ID: 12717860
    [Abstract] [Full Text] [Related]

  • 71. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator.
    Douhan J, Lieberson R, Knoll JH, Zhou H, Glimcher LH.
    J Exp Med; 1997 Jun 02; 185(11):1885-95. PubMed ID: 9166418
    [Abstract] [Full Text] [Related]

  • 72. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice.
    Clausen BE, Waldburger JM, Schwenk F, Barras E, Mach B, Rajewsky K, Förster I, Reith W.
    Immunity; 1998 Feb 02; 8(2):143-55. PubMed ID: 9491996
    [Abstract] [Full Text] [Related]

  • 73. Molecular genetics of the Bare lymphocyte syndrome.
    Masternak K, Muhlethaler-Mottet A, Villard J, Peretti M, Reith W.
    Rev Immunogenet; 2000 Feb 02; 2(2):267-82. PubMed ID: 11258423
    [Abstract] [Full Text] [Related]

  • 74. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
    Gobin SJ, Peijnenburg A, van Eggermond M, van Zutphen M, van den Berg R, van den Elsen PJ.
    Immunity; 1998 Oct 02; 9(4):531-41. PubMed ID: 9806639
    [Abstract] [Full Text] [Related]

  • 75. MHC class I and II deficiencies.
    Hanna S, Etzioni A.
    J Allergy Clin Immunol; 2014 Aug 02; 134(2):269-75. PubMed ID: 25001848
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. MHC class II expression through a hitherto unknown pathway supports T helper cell-dependent immune responses: implications for MHC class II deficiency.
    Buch T, Polic B, Clausen BE, Weiss S, Akilli-Ozturk O, Chang CH, Flavell R, Schulz A, Jonjic S, Waisman A, Förster I.
    Blood; 2006 Feb 15; 107(4):1434-44. PubMed ID: 16254146
    [Abstract] [Full Text] [Related]

  • 78. Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.
    Nickerson K, Sisk TJ, Inohara N, Yee CS, Kennell J, Cho MC, Yannie PJ, Nunez G, Chang CH.
    J Biol Chem; 2001 Jun 01; 276(22):19089-93. PubMed ID: 11279191
    [Abstract] [Full Text] [Related]

  • 79. Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3' untranslated region of the major histocompatibility complex class II transactivator gene.
    Rasmussen HB, Kelly MA, Clausen J.
    Hum Immunol; 2001 Apr 01; 62(4):371-7. PubMed ID: 11295470
    [Abstract] [Full Text] [Related]

  • 80. MHC class II deficiency: Report of a novel mutation and special review.
    Farrokhi S, Shabani M, Aryan Z, Zoghi S, Krolo A, Boztug K, Rezaei N.
    Allergol Immunopathol (Madr); 2018 Apr 01; 46(3):263-275. PubMed ID: 28676232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.